{"id":"W4401623703","doi":"10.1016/j.eururo.2024.07.016","title":"First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Occupational Cancer Research Centre; London Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Pembrolizumab; Adjuvant; Oncology; Systemic therapy; Immunotherapy; Internal medicine; Adjuvant therapy; Carcinoma; Kidney cancer; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005889523,0.0002827828,0.0003743019,0.0003442008,0.00004748818,0.00004931353,0.0002656613,0.00005315174,0.0001749969],"category_scores_gemma":[0.00001729591,0.0002202575,0.0001815731,0.0001624831,0.00003452672,0.0001248011,0.0000728116,0.0003604121,0.0002953592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001852783,"about_ca_system_score_gemma":0.00004928395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009835432,"about_ca_topic_score_gemma":0.00003301309,"domain_scores_codex":[0.9977095,0.0005439344,0.0005110154,0.0006315645,0.0002677146,0.0003363347],"domain_scores_gemma":[0.9991783,0.0001009229,0.00006467225,0.0005067663,0.00004213195,0.0001072148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004186354,0.004696453,0.8392218,0.0001225602,0.0007650251,0.05425382,0.01479103,0.0007135497,0.05828411,0.00003206778,0.0001819155,0.02275125],"study_design_scores_gemma":[0.01369154,0.006762909,0.9662949,0.000101612,0.0001322133,0.0004122245,0.0003862535,0.003459782,0.001157902,0.00000682693,0.007286755,0.0003070612],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858243,0.006423059,0.00008967194,0.0003781034,0.001181132,0.0008973647,0.000005949231,0.0001344394,0.005066015],"genre_scores_gemma":[0.9979899,0.0001886614,0.00009981234,0.0004546075,0.0004137071,0.00003784309,0.00005115321,0.0001080667,0.0006562768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1270731,"threshold_uncertainty_score":0.8981839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02542285164130504,"score_gpt":0.2802414821325394,"score_spread":0.2548186304912343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}